Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1995 1
1996 5
1997 1
1998 2
2000 2
2001 4
2002 3
2004 1
2005 1
2006 1
2007 1
2008 2
2009 5
2011 3
2012 1
2013 2
2014 1
2015 4
2016 1
2017 3
2018 8
2019 9
2020 10
2021 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.
Lescoat A, Lelong M, Jeljeli M, Piquet-Pellorce C, Morzadec C, Ballerie A, Jouneau S, Jego P, Vernhet L, Batteux F, Fardel O, Lecureur V. Lescoat A, et al. Among authors: lecureur v. Biochem Pharmacol. 2020 Aug;178:114103. doi: 10.1016/j.bcp.2020.114103. Epub 2020 Jun 17. Biochem Pharmacol. 2020. PMID: 32562787 Free article.
Beyond silicosis, is the world failing on silica hazards?
Cavalin C, Lescoat A, Ballerie A, Belhomme N, Jégo P, Jouneau S, Lecureur V, Lederlin M, Paris C, Rosental PA. Cavalin C, et al. Among authors: lecureur v. Lancet Respir Med. 2019 Aug;7(8):649-650. doi: 10.1016/S2213-2600(19)30174-2. Epub 2019 May 17. Lancet Respir Med. 2019. PMID: 31109828 Review. No abstract available.
Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis.
Bellamri N, Lelong M, Joannes A, Le Tallec E, Jouneau S, Vernhet L, Lescoat A, Lecureur V. Bellamri N, et al. Among authors: lecureur v. Int Immunopharmacol. 2023 Mar;116:109723. doi: 10.1016/j.intimp.2023.109723. Epub 2023 Jan 23. Int Immunopharmacol. 2023. PMID: 36696855 Free article.
The neglected association of crystalline silica exposure and systemic sclerosis.
Lescoat A, Ballerie A, Lecureur V, Belhomme N, Cazalets C, Jouneau S, Paris C, Menéndez-Navarro A, Rosental PA, Jégo P, Cavalin C. Lescoat A, et al. Among authors: lecureur v. Rheumatology (Oxford). 2020 Dec 1;59(12):3587-3588. doi: 10.1093/rheumatology/keaa638. Rheumatology (Oxford). 2020. PMID: 33020830 No abstract available.
The P-glycoprotein multidrug transporter.
Fardel O, Lecureur V, Guillouzo A. Fardel O, et al. Among authors: lecureur v. Gen Pharmacol. 1996 Dec;27(8):1283-91. doi: 10.1016/s0306-3623(96)00081-x. Gen Pharmacol. 1996. PMID: 9304397 Review.
Drug-induced granulomatosis: is dupilumab the new kid on the block?
Belhomme N, Gaignon T, Jouneau S, Misery L, Abasq-Thomas C, Cador B, Lecureur V, Cadiou S, Ballerie A, Polard E, Mensi S, Jego P, Lescoat A. Belhomme N, et al. Among authors: lecureur v. J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e312-e313. doi: 10.1111/jdv.16218. Epub 2020 Feb 9. J Eur Acad Dermatol Venereol. 2020. PMID: 31958359 Free article. No abstract available.
73 results